Local Arginine Supplementation Results in Sustained Wound Nitric Oxide Production and Reductions in Vascular Endothelial Growth Factor Expression and Granulation Tissue Formation

Daithi Heffernan, Ben Dudley, Paul L McNeil, Thomas R. Howdieshell

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: The goal of this work was to test the functional role of l-arginine in promotion of nitric oxide (NO) production and the vigorous granulation tissue formation characteristic of this wound model. Background: Therapeutic use of supplemental arginine has been proposed as a safe and efficacious method to produce NO from nitric oxide synthase (NOS) and to produce proline and polyamines from arginase to improve wound healing. Although NO appears to be necessary to promote wound healing, the preferential metabolism of arginine to NO via NOS 2 may be detrimental if maintained beyond the initial days of healing. Methods: A ventral hernia, surgically created in the abdominal wall of 12 swine, was repaired with silicone sheeting and skin closure. Osmotic infusion pumps, inserted in remote subcutaneous pockets, continuously delivered saline (n = 6) or l-arginine (n = 6) into the wound environment. Granulation tissue thickness was determined by ultrasonography. Fluid was aspirated serially from the wound compartment for measurements of nitrite/nitrate (NOx), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), and amino acid concentrations. On day 14, the animals were sacrificed and the abdominal wall was harvested for immunohistochemical and molecular analysis. Results: In animals receiving saline, a nearly linear four-fold increase in granulation tissue thickness was measured during the 14-day interval. In contrast, quantitative ultrasound analysis detected significant reductions in l-arginine infused granulation tissue thickness compared with controls between days 4 and 14 (P < 0.05). Wound vessel count and luminal vascular surface area estimates derived from image analysis of histological sections were two- to three-fold lower in the l-arginine animals compared with controls (P < 0.05). Significant and sustained increases in wound fluid NOx levels were noted in l-arginine animals compared to saline controls (230 μm versus 75 μm at day 14, P < 0.05). Conversely, late VEGF levels (days 11 to 14) were reduced in the l-arginine animals compared to controls (7500 pg/ml versus 10,000 pg/ml at day 11, P < 0.05; 7250 pg/ml versus 11,101 pg/ml at day 14, P < 0.05). Arginine concentrations remained two- to four-fold greater in l-arginine treated animals compared with controls over the entire time course (P < 0.05). There were no significant differences in concentrations of ornithine, citrulline, or proline noted between groups over the 14-day period. Finally, TGF-β1 levels were unaffected by l-arginine treatment. Conclusion: Although NO appears to be necessary for granulation tissue formation, early supplemental arginine may disturb the reciprocal regulation of NOS 2 and arginase, leading to the preferential metabolism of arginine to excess NO rather than ornithine, with consequent reductions in angiogenesis and granulation tissue formation.

Original languageEnglish (US)
Pages (from-to)46-54
Number of pages9
JournalJournal of Surgical Research
Volume133
Issue number1
DOIs
StatePublished - Jun 1 2006

Fingerprint

Granulation Tissue
Vascular Endothelial Growth Factor A
Arginine
Nitric Oxide
Wounds and Injuries
Nitric Oxide Synthase
Arginase
Ornithine
Transforming Growth Factors
Abdominal Wall
Proline
Wound Healing
Ventral Hernia
Infusion Pumps
Citrulline
Polyamines
Therapeutic Uses
Silicones
Nitrites
Nitrates

Keywords

  • l-arginine
  • nitric oxide synthase
  • vascular endothelial growth factor
  • wound healing

ASJC Scopus subject areas

  • Surgery

Cite this

Local Arginine Supplementation Results in Sustained Wound Nitric Oxide Production and Reductions in Vascular Endothelial Growth Factor Expression and Granulation Tissue Formation. / Heffernan, Daithi; Dudley, Ben; McNeil, Paul L; Howdieshell, Thomas R.

In: Journal of Surgical Research, Vol. 133, No. 1, 01.06.2006, p. 46-54.

Research output: Contribution to journalArticle

@article{301da4234c704d0a89e125d7f388395a,
title = "Local Arginine Supplementation Results in Sustained Wound Nitric Oxide Production and Reductions in Vascular Endothelial Growth Factor Expression and Granulation Tissue Formation",
abstract = "Objective: The goal of this work was to test the functional role of l-arginine in promotion of nitric oxide (NO) production and the vigorous granulation tissue formation characteristic of this wound model. Background: Therapeutic use of supplemental arginine has been proposed as a safe and efficacious method to produce NO from nitric oxide synthase (NOS) and to produce proline and polyamines from arginase to improve wound healing. Although NO appears to be necessary to promote wound healing, the preferential metabolism of arginine to NO via NOS 2 may be detrimental if maintained beyond the initial days of healing. Methods: A ventral hernia, surgically created in the abdominal wall of 12 swine, was repaired with silicone sheeting and skin closure. Osmotic infusion pumps, inserted in remote subcutaneous pockets, continuously delivered saline (n = 6) or l-arginine (n = 6) into the wound environment. Granulation tissue thickness was determined by ultrasonography. Fluid was aspirated serially from the wound compartment for measurements of nitrite/nitrate (NOx), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), and amino acid concentrations. On day 14, the animals were sacrificed and the abdominal wall was harvested for immunohistochemical and molecular analysis. Results: In animals receiving saline, a nearly linear four-fold increase in granulation tissue thickness was measured during the 14-day interval. In contrast, quantitative ultrasound analysis detected significant reductions in l-arginine infused granulation tissue thickness compared with controls between days 4 and 14 (P < 0.05). Wound vessel count and luminal vascular surface area estimates derived from image analysis of histological sections were two- to three-fold lower in the l-arginine animals compared with controls (P < 0.05). Significant and sustained increases in wound fluid NOx levels were noted in l-arginine animals compared to saline controls (230 μm versus 75 μm at day 14, P < 0.05). Conversely, late VEGF levels (days 11 to 14) were reduced in the l-arginine animals compared to controls (7500 pg/ml versus 10,000 pg/ml at day 11, P < 0.05; 7250 pg/ml versus 11,101 pg/ml at day 14, P < 0.05). Arginine concentrations remained two- to four-fold greater in l-arginine treated animals compared with controls over the entire time course (P < 0.05). There were no significant differences in concentrations of ornithine, citrulline, or proline noted between groups over the 14-day period. Finally, TGF-β1 levels were unaffected by l-arginine treatment. Conclusion: Although NO appears to be necessary for granulation tissue formation, early supplemental arginine may disturb the reciprocal regulation of NOS 2 and arginase, leading to the preferential metabolism of arginine to excess NO rather than ornithine, with consequent reductions in angiogenesis and granulation tissue formation.",
keywords = "l-arginine, nitric oxide synthase, vascular endothelial growth factor, wound healing",
author = "Daithi Heffernan and Ben Dudley and McNeil, {Paul L} and Howdieshell, {Thomas R.}",
year = "2006",
month = "6",
day = "1",
doi = "10.1016/j.jss.2006.03.028",
language = "English (US)",
volume = "133",
pages = "46--54",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Local Arginine Supplementation Results in Sustained Wound Nitric Oxide Production and Reductions in Vascular Endothelial Growth Factor Expression and Granulation Tissue Formation

AU - Heffernan, Daithi

AU - Dudley, Ben

AU - McNeil, Paul L

AU - Howdieshell, Thomas R.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Objective: The goal of this work was to test the functional role of l-arginine in promotion of nitric oxide (NO) production and the vigorous granulation tissue formation characteristic of this wound model. Background: Therapeutic use of supplemental arginine has been proposed as a safe and efficacious method to produce NO from nitric oxide synthase (NOS) and to produce proline and polyamines from arginase to improve wound healing. Although NO appears to be necessary to promote wound healing, the preferential metabolism of arginine to NO via NOS 2 may be detrimental if maintained beyond the initial days of healing. Methods: A ventral hernia, surgically created in the abdominal wall of 12 swine, was repaired with silicone sheeting and skin closure. Osmotic infusion pumps, inserted in remote subcutaneous pockets, continuously delivered saline (n = 6) or l-arginine (n = 6) into the wound environment. Granulation tissue thickness was determined by ultrasonography. Fluid was aspirated serially from the wound compartment for measurements of nitrite/nitrate (NOx), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), and amino acid concentrations. On day 14, the animals were sacrificed and the abdominal wall was harvested for immunohistochemical and molecular analysis. Results: In animals receiving saline, a nearly linear four-fold increase in granulation tissue thickness was measured during the 14-day interval. In contrast, quantitative ultrasound analysis detected significant reductions in l-arginine infused granulation tissue thickness compared with controls between days 4 and 14 (P < 0.05). Wound vessel count and luminal vascular surface area estimates derived from image analysis of histological sections were two- to three-fold lower in the l-arginine animals compared with controls (P < 0.05). Significant and sustained increases in wound fluid NOx levels were noted in l-arginine animals compared to saline controls (230 μm versus 75 μm at day 14, P < 0.05). Conversely, late VEGF levels (days 11 to 14) were reduced in the l-arginine animals compared to controls (7500 pg/ml versus 10,000 pg/ml at day 11, P < 0.05; 7250 pg/ml versus 11,101 pg/ml at day 14, P < 0.05). Arginine concentrations remained two- to four-fold greater in l-arginine treated animals compared with controls over the entire time course (P < 0.05). There were no significant differences in concentrations of ornithine, citrulline, or proline noted between groups over the 14-day period. Finally, TGF-β1 levels were unaffected by l-arginine treatment. Conclusion: Although NO appears to be necessary for granulation tissue formation, early supplemental arginine may disturb the reciprocal regulation of NOS 2 and arginase, leading to the preferential metabolism of arginine to excess NO rather than ornithine, with consequent reductions in angiogenesis and granulation tissue formation.

AB - Objective: The goal of this work was to test the functional role of l-arginine in promotion of nitric oxide (NO) production and the vigorous granulation tissue formation characteristic of this wound model. Background: Therapeutic use of supplemental arginine has been proposed as a safe and efficacious method to produce NO from nitric oxide synthase (NOS) and to produce proline and polyamines from arginase to improve wound healing. Although NO appears to be necessary to promote wound healing, the preferential metabolism of arginine to NO via NOS 2 may be detrimental if maintained beyond the initial days of healing. Methods: A ventral hernia, surgically created in the abdominal wall of 12 swine, was repaired with silicone sheeting and skin closure. Osmotic infusion pumps, inserted in remote subcutaneous pockets, continuously delivered saline (n = 6) or l-arginine (n = 6) into the wound environment. Granulation tissue thickness was determined by ultrasonography. Fluid was aspirated serially from the wound compartment for measurements of nitrite/nitrate (NOx), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), and amino acid concentrations. On day 14, the animals were sacrificed and the abdominal wall was harvested for immunohistochemical and molecular analysis. Results: In animals receiving saline, a nearly linear four-fold increase in granulation tissue thickness was measured during the 14-day interval. In contrast, quantitative ultrasound analysis detected significant reductions in l-arginine infused granulation tissue thickness compared with controls between days 4 and 14 (P < 0.05). Wound vessel count and luminal vascular surface area estimates derived from image analysis of histological sections were two- to three-fold lower in the l-arginine animals compared with controls (P < 0.05). Significant and sustained increases in wound fluid NOx levels were noted in l-arginine animals compared to saline controls (230 μm versus 75 μm at day 14, P < 0.05). Conversely, late VEGF levels (days 11 to 14) were reduced in the l-arginine animals compared to controls (7500 pg/ml versus 10,000 pg/ml at day 11, P < 0.05; 7250 pg/ml versus 11,101 pg/ml at day 14, P < 0.05). Arginine concentrations remained two- to four-fold greater in l-arginine treated animals compared with controls over the entire time course (P < 0.05). There were no significant differences in concentrations of ornithine, citrulline, or proline noted between groups over the 14-day period. Finally, TGF-β1 levels were unaffected by l-arginine treatment. Conclusion: Although NO appears to be necessary for granulation tissue formation, early supplemental arginine may disturb the reciprocal regulation of NOS 2 and arginase, leading to the preferential metabolism of arginine to excess NO rather than ornithine, with consequent reductions in angiogenesis and granulation tissue formation.

KW - l-arginine

KW - nitric oxide synthase

KW - vascular endothelial growth factor

KW - wound healing

UR - http://www.scopus.com/inward/record.url?scp=33646249376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646249376&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2006.03.028

DO - 10.1016/j.jss.2006.03.028

M3 - Article

VL - 133

SP - 46

EP - 54

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -